<VariationArchive RecordType="classified" VariationID="218098" VariationName="NM_001172509.1(SATB2):c.170_346dup" VariationType="Duplication" Accession="VCV000218098" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2015-11-26" MostRecentSubmission="2015-11-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="214752" VariationID="218098">
      <GeneList>
        <Gene Symbol="SATB2" FullName="SATB homeobox 2" GeneID="23314" HGNC_ID="HGNC:21637" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199269500" stop="199471266" display_start="199269500" display_stop="199471266" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200134222" stop="200335988" display_start="200134222" display_stop="200335988" Strand="-" />
          </Location>
          <OMIM>608148</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001172509.1(SATB2):c.170_346dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199391823" stop="199446462" display_start="199391823" display_stop="199446462" Strand="-" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200298061" stop="200298237" display_start="200298061" display_stop="200298237" variantLength="177" />
      </Location>
      <OtherNameList>
        <Name>54-KB DUP, EX3</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172509.1" sequenceAccession="NM_001172509" sequenceVersion="1" change="c.169+9407_347-10003dup">
            <Expression>NM_001172509.1:c.169+9407_347-10003dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608148.0003" DB="OMIM" />
        <XRef Type="rs" ID="2105928778" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="LocationOnGenomeAndProductNotAligned">As described in PMID 25118029, PCR shows that the chromosomal duplication from intron 2 to intron 3 results in an in-frame tandem duplication of exon 3 of NM_001172509.1 for gene SATB2.</Comment>
      <Comment DataSource="NCBI curation" Type="public">54.6-kb chromosomal duplication within gene SATB2 starting in intron 3 and ending in intron 4, straddling exon 4 from NG_016976.1. This results in an in-frame tandem duplication of exon 3 of NM_001172509.1.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001172509.1(SATB2):c.170_346dup AND Chromosome 2q32-q33 deletion syndrome" Accession="RCV000202349" Version="2">
        <ClassifiedConditionList TraitSetID="10106">
          <ClassifiedCondition DB="MedGen" ID="C2676739">Chromosome 2q32-q33 deletion syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-11-26" MostRecentSubmission="2015-11-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25118029</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1446" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glass syndrome</ElementValue>
                <XRef Type="Allelic variant" ID="608148.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608148.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608148.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Chromosome 2q32-q33 deletion syndrome</ElementValue>
                <XRef ID="MONDO:0012864" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">2q33.1 deletion syndrome</ElementValue>
                <XRef ID="51" DB="Decipher" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GLASS</ElementValue>
                <XRef Type="MIM" ID="612313" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SATB2-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited to absent speech, behavioral issues, and craniofacial anomalies. All individuals described to date have manifest developmental delay / intellectual disability, with severe speech delay. Affected individuals often have hypotonia and feeding difficulties in infancy. Behavioral issues may include autistic features, hyperactivity, and aggressiveness. Craniofacial anomalies may include palatal abnormalities (cleft palate, high-arched palate, and bifid uvula), micrognathia, and abnormal shape or size of the upper central incisors. Less common features include skeletal anomalies (osteopenia, pectus deformities, kyphosis/lordosis, and scoliosis), growth restriction, strabismus/refractive errors, congenital heart defects, genitourinary anomalies, and epilepsy. While dysmorphic features have been described in individuals with this condition, these features are not typically distinctive enough to allow for a clinical diagnosis of SAS.</Attribute>
                <XRef ID="NBK458647" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13206" />
                <XRef ID="13206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="Decipher">
                <URL>https://decipher.sanger.ac.uk/syndrome/51</URL>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29023086</ID>
                <ID Source="BookShelf">NBK458647</ID>
              </Citation>
              <XRef ID="251019" DB="Orphanet" />
              <XRef ID="C2676739" DB="MedGen" />
              <XRef ID="MONDO:0012864" DB="MONDO" />
              <XRef Type="MIM" ID="612313" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="480245" SubmissionDate="2015-12-01" DateLastUpdated="2015-11-26" DateCreated="2015-11-26">
        <ClinVarSubmissionID localKey="608148.0003_GLASS SYNDROME" title="SATB2, 54-KB DUP, EX3_GLASS SYNDROME" />
        <ClinVarAccession Accession="SCV000257342" DateUpdated="2015-11-26" DateCreated="2015-11-26" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 10-year-old German girl with Glass syndrome (GLASS; 612313), Kaiser et al. (2015) identified a de novo heterozygous 54-kb duplication (c.169+9407_347-10003dup, NM_001172509.1) of exon 3 in the SATB2 gene. Sanger sequence analysis and studies of patient transcripts confirmed that the duplication was in tandem and resulted in an in-frame duplication of exon 3. The patient was born of unrelated parents and conceived via intracytoplasmic sperm injection. Further molecular studies were not performed; the authors postulated that the mutation resulted in haploinsufficiency.</Attribute>
              <Citation>
                <ID Source="PubMed">25118029</ID>
              </Citation>
              <XRef DB="OMIM" ID="612313" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SATB2" />
          </GeneList>
          <Name>SATB2, 54-KB DUP, EX3</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">54-KB DUP, EX3</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608148.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLASS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="480245" TraitType="Disease" MappingType="Name" MappingValue="GLASS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C2676739" Name="Chromosome 2q32-q33 deletion syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

